AppPage.net

Screenshots

  • J3M-MC-JZQB CN screenshot 1
  • J3M-MC-JZQB CN screenshot 2
  • J3M-MC-JZQB CN screenshot 3
  • J3M-MC-JZQB CN screenshot 4

About J3M-MC-JZQB CN

A Multicenter, Randomized, Phase 3 Study Comparing LY3537982 and Pembrolizumab to Placebo and Pembrolizumab as First-Line Treatment in Patients with KRAS G12C-Mutant, Locally Advanced or Metastatic Non-Small Cell Lung Cancer with High PD-L1 Expression (TPS ≥ 50%). This app is specifically intended for participants in the J3M-MC-JZQB study only.

What’s new

Version 5.4.1101 · Updated November 20, 2025

This update includes improvements and bug fixes to enhance your experience.

App privacy

The developer, Medable, Inc., reported these privacy practices to Apple.

Data Linked to You

The following data, which may be collected and linked to your identity, may be used for the following purposes:

  • Health & Fitness: Health
  • Identifiers: User ID
  • Diagnostics: Crash Data, Other Diagnostic Data

Used for: App Functionality

Alternatives to J3M-MC-JZQB CN

Looking for apps like J3M-MC-JZQB CN? Here are 6 similar apps on the App Store. The highest rated is Dose Hot Pilates and Yoga (5.0/5), and all 6 are free to download.

J3M-MC-JZQB CN vs. alternatives
App Rating Price Last updated Compare
J3M-MC-JZQB CN – Free November 20, 2025
Clinical ink Early Look – Free Oct 22, 2026 Compare
Clinical Ink Engage (EU) 2.6 / 5 (14) Free Aug 28, 2026 Compare
Dose Hot Pilates and Yoga 5.0 / 5 (2) Free Jun 17, 2026 Compare
YPrime eCOA 2.9 / 5 (15) Free Nov 20, 2024 Compare
Clinical ink 2.0 / 5 (7) Free Oct 22, 2026 Compare
GHA Health 5.0 / 5 (2) Free Sep 10, 2026 Compare

Compare J3M-MC-JZQB CN with the top alternatives: ratings, updates, ASO score and keyword gaps →